WO2011104695A3 - Detection of kras mutation in exon 2 by allele specific real time quantitative pcr (as-qpcr) - Google Patents

Detection of kras mutation in exon 2 by allele specific real time quantitative pcr (as-qpcr) Download PDF

Info

Publication number
WO2011104695A3
WO2011104695A3 PCT/IB2011/050819 IB2011050819W WO2011104695A3 WO 2011104695 A3 WO2011104695 A3 WO 2011104695A3 IB 2011050819 W IB2011050819 W IB 2011050819W WO 2011104695 A3 WO2011104695 A3 WO 2011104695A3
Authority
WO
WIPO (PCT)
Prior art keywords
allele
qpcr
exon
detection
real time
Prior art date
Application number
PCT/IB2011/050819
Other languages
French (fr)
Other versions
WO2011104695A2 (en
Inventor
Luca Morandi
Original Assignee
GAMMAGENETICS Sàrl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GAMMAGENETICS Sàrl filed Critical GAMMAGENETICS Sàrl
Publication of WO2011104695A2 publication Critical patent/WO2011104695A2/en
Publication of WO2011104695A3 publication Critical patent/WO2011104695A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6858Allele-specific amplification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism

Abstract

A method for conducting an allele specific polymerase chain reaction which comprises subjecting DNA which may contain either or both of first and second alleles to a polymerase chain reaction utilizing a primer pair in which one of the primers is complementary to said first allele, but which primer forms a mismatch with said second allele at the 3'-terminal nucleotide of the primer, and utilizing a DNA polymerase wherein said first allele is specifically amplified but no amplification of said second allele occurs.
PCT/IB2011/050819 2010-02-26 2011-02-25 Detection of kras mutation in exon 2 by allele specific real time quantitative pcr (as-qpcr) WO2011104695A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB2010050843 2010-02-26
IBPCT/IB2010/050843 2010-02-26

Publications (2)

Publication Number Publication Date
WO2011104695A2 WO2011104695A2 (en) 2011-09-01
WO2011104695A3 true WO2011104695A3 (en) 2012-03-01

Family

ID=44507312

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2011/050819 WO2011104695A2 (en) 2010-02-26 2011-02-25 Detection of kras mutation in exon 2 by allele specific real time quantitative pcr (as-qpcr)

Country Status (1)

Country Link
WO (1) WO2011104695A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102367478B (en) * 2011-10-25 2013-07-31 浙江大学 ARMS-qPCR (Allele Refractory Mutation System-quantitative Polymerase Chain Reaction) detection kit for KRAS (Kirsten Rat Sarcoma Viral Oncogene Homolog) gene mutation subtype and detection method
CN103930571A (en) * 2011-11-17 2014-07-16 瑞尼克斯有限公司 System and methods for selective molecular analysis
CN102796816B (en) * 2012-07-06 2014-04-16 陕西北美基因股份有限公司 Method for performing in-vitro accurate test on KRAS gene mutation
WO2014052613A2 (en) * 2012-09-26 2014-04-03 Insight Genetics, Inc. Methods and compositions relating to next generation sequencing for genetic testing in alk related cancers
CN104805207A (en) * 2015-04-29 2015-07-29 苏州工业园区为真生物医药科技有限公司 Kit for detecting kras gene mutation, and detection method of kit
JP6754202B2 (en) * 2016-03-15 2020-09-09 アークレイ株式会社 K-ras gene amplification forward primer set, K-ras gene amplification kit, K-ras gene amplification method, polymorphism analysis method, and drug efficacy determination method

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639611A (en) * 1988-12-12 1997-06-17 City Of Hope Allele specific polymerase chain reaction
WO2000056916A2 (en) * 1999-03-18 2000-09-28 Exiqon A/S Detection of mutations in genes by specific lna primers
EP1247815A2 (en) * 2001-03-25 2002-10-09 Exiqon A/S Modified oligonucleotides and uses thereof
WO2003072814A2 (en) * 2002-02-26 2003-09-04 Roche Diagnostics Gmbh Improved method for allele-specific pcr
WO2008070370A2 (en) * 2006-11-02 2008-06-12 University Of Utah Research Foundation Oligonucleotides for use in allele-specific pcr

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639611A (en) * 1988-12-12 1997-06-17 City Of Hope Allele specific polymerase chain reaction
WO2000056916A2 (en) * 1999-03-18 2000-09-28 Exiqon A/S Detection of mutations in genes by specific lna primers
EP1247815A2 (en) * 2001-03-25 2002-10-09 Exiqon A/S Modified oligonucleotides and uses thereof
WO2003072814A2 (en) * 2002-02-26 2003-09-04 Roche Diagnostics Gmbh Improved method for allele-specific pcr
WO2008070370A2 (en) * 2006-11-02 2008-06-12 University Of Utah Research Foundation Oligonucleotides for use in allele-specific pcr

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JOHNSON M P ET AL: "LOCKED NUCLEIC ACID (LNA) SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPE ANALYSIS AND VALIDATION USING REAL-TIME PCR", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 32, no. 6, 26 March 2004 (2004-03-26), pages E55 - 01, XP009069933, ISSN: 0305-1048 *
LATORRA D ET AL: "ENHANCED ALLELE-SPECIFIC PCR DISCRIMINATION IN SNP GENOTYPING USING 3' LOCKED NUCLEIC ACID (LNA) PRIMERS", HUMAN MUTATION, JOHN WILEY & SONS, INC, US, vol. 22, no. 1, 1 July 2003 (2003-07-01), pages 79 - 85, XP009043978, ISSN: 1059-7794, DOI: 10.1002/HUMU.10228 *
STRAND ET AL: "Real-time detection and quantification of mitochondrial mutations with oligonucleotide primers containing locked nucleic acid", CLINICA CHIMICA ACTA, ELSEVIER BV, AMSTERDAM, NL, vol. 390, no. 1-2, 16 January 2008 (2008-01-16), pages 126 - 133, XP022499213, ISSN: 0009-8981, DOI: 10.1016/J.CCA.2008.01.010 *

Also Published As

Publication number Publication date
WO2011104695A2 (en) 2011-09-01

Similar Documents

Publication Publication Date Title
Jiang et al. Robust strand exchange reactions for the sequence-specific, real-time detection of nucleic acid amplicons
WO2008034110A3 (en) Use of taq polymerase mutant enzymes for dna amplification in the presence of pcr inhibitors
EP1845160A4 (en) Method for amplification of nucleotide sequence
WO2008084405A3 (en) Circular chromosome conformation capture (4c)
WO2007004057A3 (en) Chromosome conformation capture-on-chip (4c) assay
WO2007110656A3 (en) Methods and apparatus for genotyping
WO2011106724A3 (en) Fast pcr for str genotyping
WO2011104695A3 (en) Detection of kras mutation in exon 2 by allele specific real time quantitative pcr (as-qpcr)
MX346956B (en) Direct capture, amplification and sequencing of target dna using immobilized primers.
WO2009086608A3 (en) Method and kit to perform a pcr amplification and micro- array detection in the same medium and/or same chamber
WO2007139723A8 (en) Chemicallymodified oligonucleotide primers for nucleic acid amplification
WO2006074222A3 (en) Primer for nucleic acid detection
WO2012093262A3 (en) Mutational analysis
WO2008069906A3 (en) Digital expression of gene analysis
WO2008033442A3 (en) Methods and compositions for performing low background multiplex nucleic acid amplification reactions
AU2009355009A8 (en) THD primer target detection
WO2012067830A3 (en) Methylation assay
WO2008122002A3 (en) Organism identification panel
WO2008054834A3 (en) Binary deoxyribozyme probes for nucleic acid analysis
Direito et al. Systematic evaluation of bias in microbial community profiles induced by whole genome amplification
WO2012046981A3 (en) Real time pcr detection of single nucleotide polymorphisms
WO2014052487A8 (en) Two-primer pcr for microrna multiplex assay
PT1907588E (en) Assays for resistance to echinocandin-class drugs
WO2011140187A3 (en) Detecting chromosomal rearrangement
WO2011104694A3 (en) Detection of braf v600e mutation by allele specific real time quantitative pcr (as-qpcr) using locked nucleic acids primers and beacon probes

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11729338

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11729338

Country of ref document: EP

Kind code of ref document: A2